Publications by authors named "Ed Casson"

Claim this Profile
A
A Phase 1, open-label, multicentre study to compare the capsule and tablet formulations of AZD5363 and explore the effect of food on the pharmacokinetic exposure, safety and tolerability of AZD5363 in patients with advanced solid malignancies: OAK.
Emma Dean, Udai Banerji, Jan H M Schellens, Matthew G Krebs, Begona Jimenez, Ed Casson

Cancer Chemother Pharmacol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain.
Stephen Daniels, Ed Casson, Jens-Ulrich Stegmann, Charles Oh, Akiko Okamoto

Curr Med Res Opin· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis